首页|期刊导航|生物信息学|基于网络药理学探讨山奈酚干预肝癌的作用机制

基于网络药理学探讨山奈酚干预肝癌的作用机制OA

Study on the mechanism of kaempferol intervention in liver cancer based on network pharmacology

中文摘要英文摘要

为基于网络药理学探讨山奈酚治疗肝癌的潜在靶点和作用机制.通过 SwissTargetPrediction 数据库、CTD 数据库和TCMSP 数据库筛选出山奈酚的作用靶点,采用差异分析和加权基因共表达网络分析(WGCNA)确定肝癌中的差异基因和模块基因.通过对靶点进行生物过程及通路分析构建蛋白质相互作用(PPI)网络.对作用靶点进行基因本体(GO)与京都基因与基因组百科全书(KEGG)分析,并运用 MCC、Degree 和 BotttleNeck 算法筛选出关键靶点基因.基于关键靶点基因构建预测肝癌发生的列线图,采用受试者工作特征(ROC)曲线评估关键靶点基因对肝癌的预测价值.利用 GEPIA2 数据库分析关键靶点基因在肝癌组织中的表达水平,并进行预后生存分析.采用分子对接技术分析山奈酚与关键靶点之间的相互作用.结果发现:在 434 个山奈酚作用靶点、829 个肝癌差异基因和 4 231 个 WGCNA 关联模块基因中取交集得到 20 个与山奈酚治疗肝癌相关的靶点基因.通过 GO 与 KEGG 分析发现这20 个靶点主要涉及细胞周期、p53 信号通路、FoxO 信号通路及 MAPK 信号通路,并从中筛选出 3 个关键靶点基因:CDK1、SFN、TOP2A.GEPIA2 数据库分析结果显示,关键靶点基因 CDK1、SFN、TOP2A 在肝癌组织中表达上调.基于关键靶点基因构建的列线图模型对肝癌发生具有较高的预测价值,生存分析显示关键靶点基因低表达组生存率均高于高表达组.分子对接实验结果证明了山奈酚活性成分与关键靶点 CDK1、SFN、TOP2A 具有较好的结合力.本研究初步揭示了山奈酚可能通过调节细胞周期、p53 信号通路、FoxO 信号通路及 MAPK 信号通路治疗肝癌,通过CDK1、SFN、TOP2A 等关键靶点基因影响治疗效果,为进一步深入探讨山奈酚治疗肝癌提供了理论支持.

Exploring the potential targets and mechanisms of action of salvianolic acid in the treatment of liver cancer based on network pharmacology.The targets of kaempferol were screened by SwissTargetPrediction database,CTD database and TCMSP database,the differential genes and module genes in liver cancer were identified by differential analysis and weighted gene co-expression network analysis(WGCNA).A protein-protein interaction(PPI)network was constructed by analyzing the biological processes and pathways of the targets.Gene ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)analysis were performed on the targets,and MCC,Degree and BotttleNeck algorithms were used to screen out the key target genes.A nomogram was constructed to predict the occurrence of liver cancer based on the key target genes,and the predictive value of key target genes for liver cancer was evaluated by receiver operating characteristic(ROC)curve.The expression level of key target genes in liver cancer tissues was analyzed by GEPIA2 database,and prognostic survival analysis was performed.The interaction between kaempferol and key targets was analyzed by molecular docking technology.A total of 20 target genes related to kaempferol in the treatment of liver cancer were obtained from the intersection of 434 kaempferol targets,829 liver cancer differential genes and 4231 WGCNA associated module genes.Tt was found that these 20 targets were mainly involved in cell cycle,p53 signaling pathway,FoxO signaling pathway and MAPK signaling pathway through GO and KEGG analysis,and three key target genes were screened out:CDK1,SFN and TOP2A.The results of GEPIA2 database analysis showed that,the expression of key target genes CDK1,SFN and TOP2A was up-regulated in HCC tissues.The nomogram model based on key target genes has a high predictive value for the occurrence of liver cancer.,survival analysis showed that the survival rate in low expression group of key target genes was higher than that in high expression group.The results of molecular docking experiments showed that the active components of kaempferol had good binding force with the key targets CDK1,SFN and TOP2A.This study preliminarily reveal that kaempferol may treat liver cancer by regulating cell cycle,p53 signaling pathway,FoxO signaling pathway and MAPK signaling pathway,and affect the therapeutic effect through key target genes such as CDK1,SFN and TOP2A,which provides theoretical support for further exploration of kaempferol in the treatment of liver cancer.

李春华;陈静;付琴琴

湖北省直属机关医院/湖北省康复医院,药剂科 武汉 430071湖北省直属机关医院/湖北省康复医院,消化科 武汉 430071武汉药品医疗器械检验所 武汉 430073

山奈酚肝癌网络药理学作用机制

KaempferolLiver cancerNetwork pharmacologyMechanism of action

《生物信息学》 2026 (3)

263-273,11

湖北省中医药管理局中医药科研项目(No.ZY2023F034).

10.12113/202411008

评论